Sector ratings DexCom, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-31 EDT			5-day change	1st Jan Change
91.06 ^USD	+0.26%		-.--%	+37.20%

08-24	Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing	MT
08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
DEXCOM, INC.	34.36B	BBB
ABBOTT LABORATORIES	191B	BBB
MEDTRONIC PLC	116B	BBB
CENCORA, INC.	61.75B	AA
BECTON, DICKINSON AND COMPANY	51.24B	A
HOYA CORPORATION	51.51B	AAA
MEDLINE INC.	30.73B	A
WEST PHARMACEUTICAL SERVICES, INC.	24.01B	AA
TERUMO CORPORATION	23.23B	AA
STERIS PLC	22.68B	AAA	-
SARTORIUS STEDIM BIOTECH	22.15B	BBB
ZIMMER BIOMET HOLDINGS, INC.	19.08B	A
SOLVENTUM CORPORATION	15.5B	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.41B	A
BAXTER INTERNATIONAL INC.	13.44B	A
ALIGN TECHNOLOGY, INC.	11.35B	A
GLOBUS MEDICAL, INC.	10.92B	CCC
BIO-RAD LABORATORIES, INC.	10.22B	BBB	-
INSULET CORPORATION	10.31B	A
REPLIGEN CORPORATION	10.21B	AA
Average	37.26B	A
Weighted average by Cap.		A